Literature DB >> 18092919

Advances in microRNAs: implications for gene therapists.

Rebecca T Marquez1, Anton P McCaffrey.   

Abstract

MicroRNAs (miRNAs) are a class of small regulatory RNAs that are thought to regulate the expression of as many as one-third of all human messenger RNAs (mRNAs). miRNAs are thought to be involved in diverse biological processes, including tumorigenesis. Analysis of miRNA levels may have diagnostic implications. Evidence shows that numerous viruses interact with the miRNA machinery, and that a number of viruses encode their own miRNAs. It seems likely that miRNAs will be implicated in many human diseases. Manipulation of miRNA levels by gene therapy provides an attractive new approach for therapeutic development. This review focuses on approaches to manipulate miRNA levels in cells and in vivo, and the implications for gene therapy. Furthermore, we discuss the use of endogenous miRNAs as scaffolds for the expression of RNA interference (RNAi) as well as competition between exogenous RNAi triggers and endogenous miRNAs. Because short interfering RNAs can also act as miRNAs, seed matches with the 3' untranslated regions of genes should be avoided to prevent off-target effects. Last, we discuss the use of miRNAs to avoid immune responses to viral vectors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18092919      PMCID: PMC2760384          DOI: 10.1089/hum.2007.147

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  108 in total

1.  Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.

Authors:  Valerio Fulci; Sabina Chiaretti; Marina Goldoni; Gianluca Azzalin; Nicoletta Carucci; Simona Tavolaro; Leandro Castellano; Armando Magrelli; Franca Citarella; Monica Messina; Roberta Maggio; Nadia Peragine; Simona Santangelo; Francesca Romana Mauro; Pablo Landgraf; Thomas Tuschl; David B Weir; Minchen Chien; James J Russo; Jingyue Ju; Robert Sheridan; Chris Sander; Mihaela Zavolan; Anna Guarini; Robin Foà; Giuseppe Macino
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

Review 2.  MicroRNAs in viral replication and pathogenesis.

Authors:  Derek M Dykxhoorn
Journal:  DNA Cell Biol       Date:  2007-04       Impact factor: 3.311

Review 3.  Argonaute proteins: mediators of RNA silencing.

Authors:  Lasse Peters; Gunter Meister
Journal:  Mol Cell       Date:  2007-06-08       Impact factor: 17.970

4.  miR-21-mediated tumor growth.

Authors:  M-L Si; S Zhu; H Wu; Z Lu; F Wu; Y-Y Mo
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

5.  Cloning and analysis of microRNAs encoded by the primate gamma-herpesvirus rhesus monkey rhadinovirus.

Authors:  Alexandra Schäfer; Xuezhong Cai; John P Bilello; Ronald C Desrosiers; Bryan R Cullen
Journal:  Virology       Date:  2007-04-23       Impact factor: 3.616

Review 6.  DNA methyltransferase inhibitors for cancer therapy.

Authors:  Bodo Brueckner; Dirk Kuck; Frank Lyko
Journal:  Cancer J       Date:  2007 Jan-Feb       Impact factor: 3.360

7.  MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

Authors:  Shuomin Zhu; Min-Liang Si; Hailong Wu; Yin-Yuan Mo
Journal:  J Biol Chem       Date:  2007-03-15       Impact factor: 5.157

8.  microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.

Authors:  Diana O Perkins; Clark D Jeffries; L Fredrik Jarskog; J Michael Thomson; Keith Woods; Martin A Newman; Joel S Parker; Jianping Jin; Scott M Hammond
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

9.  Specificity, duplex degradation and subcellular localization of antagomirs.

Authors:  Jan Krützfeldt; Satoru Kuwajima; Ravi Braich; Kallanthottathil G Rajeev; John Pena; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

10.  Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1.

Authors:  Yongxiu Yao; Yuguang Zhao; Hongtao Xu; Lorraine P Smith; Charles H Lawrie; Alain Sewer; Mihaela Zavolan; Venugopal Nair
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

View more
  18 in total

1.  miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.

Authors:  Deena M Leslie Pedrioli; Terhi Karpanen; Vasilios Dabouras; Giorgia Jurisic; Glenn van de Hoek; Jay W Shin; Daniela Marino; Roland E Kälin; Sebastian Leidel; Paolo Cinelli; Stefan Schulte-Merker; André W Brändli; Michael Detmar
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

2.  [Molecular pathology as an necessity: its role in diagnostic and predictive pathology].

Authors:  K W Schmid
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

3.  MicroRNA 21 blocks apoptosis in mouse periovulatory granulosa cells.

Authors:  Martha Z Carletti; Stephanie D Fiedler; Lane K Christenson
Journal:  Biol Reprod       Date:  2010-03-31       Impact factor: 4.285

Review 4.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

5.  Creating a flexible multiple microRNA expression vector by linking precursor microRNAs.

Authors:  Xiangning Qiu; Jeffrey M Friedman; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2011-06-24       Impact factor: 3.575

6.  miRNA-Based Therapeutic Strategies.

Authors:  Masaharu Ishida; Florin M Selaru
Journal:  Curr Anesthesiol Rep       Date:  2012-12-24

7.  Forward and robust selection of the most potent and noncellular toxic siRNAs from RNAi libraries.

Authors:  Zhen Li; Yves Fortin; Shi-Hsiang Shen
Journal:  Nucleic Acids Res       Date:  2008-11-29       Impact factor: 16.971

Review 8.  Selective gene silencing by viral delivery of short hairpin RNA.

Authors:  Katja Sliva; Barbara S Schnierle
Journal:  Virol J       Date:  2010-09-21       Impact factor: 4.099

9.  MicroRNA: An emerging therapeutic target and intervention tool.

Authors:  Zhen Liu; Alhousseynou Sall; Decheng Yang
Journal:  Int J Mol Sci       Date:  2008-06-13       Impact factor: 6.208

10.  Formulation of New Algorithmics for miRNAs.

Authors:  Yoichi Robertus Fujii
Journal:  Open Virol J       Date:  2008-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.